Clinical Trial Update: To Evaluate the Effect of Nesinaact on Non-alcoholic Steatohepatitis Through MRI and Liver Fibroscan in Patients With Type 2 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the effect of Nesinaact on non-alcoholic steatohepatitis in patients with type 2 diabetes using MRI and liver elastography.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Steatohepatitis
• Type 2 Diabetes Mellitus

Drugs mentioned

• Nesinaact

Snippet

Sponsor: Yonsei University | Conditions: Non-alcoholic Steatohepatitis, Type2 Diabetes | Phase 4 | Status: UNKNOWN